The treatment of renal cell carcinoma with human leukocyte alpha - interferon. (jcancer.org)
A Phase III, Multicenter, Randomized, Placebo - Controlled, Double - Blind Study Of Atezolizumab (Anti − PD - L1 Antibody) As Adjuvant Therapy In Patients With Renal Cell Carcinoma At High Risk Of Developing Metastasis Following Nephrectomy (vicc.org)
Based on this finding, the researchers found that similar mutations also occur in renal cell carcinomas in humans. (sciencedaily.com)